Navigation Links
Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
Date:3/8/2011

xpertise or to otherwise manage its growth; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products under its license and sublicense agreements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2009 and quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2010, which are on file with the SEC and available on the SEC's website at http://www.sec.gov/.  Additional information will also be set forth in those sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2010, which will be filed with the SEC in the first quarter of 2011.  In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to updat
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers ... technologies must be able to protect their ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) ... of the Medical Device Industry, it steadfastly ... sectors of cases involving IP infringement. This ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... company developing its Symphony® CGM System as a ... that Robert F. Doman , Executive Chairman ... at "TEN", Noble Financial Capital Markets, Tenth Annual ... make a corporate presentation to prospective corporate partners ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... market research report is available in its ... Dermatitis - India Drug Forecast and Market ... PharmaPoint: Atopic Dermatitis - ... 2022 Summary,Although the past decade ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... Institute, the leading provider of specialized training solutions ... subsidiary of Campbell Alliance, announced today the completion ... Area Essentials™ e-course series.  This series ... biotech R&D and commercial professionals.  It includes 155 ...
... Calif., June 20, 2011 Inogen has been honored ... the Inogen One Portable Oxygen Concentrator.  The Medical Design ... exclusively recognizes contributions and advances in the design of ... by Goleta, California based Inogen, Inc. is used to ...
Cached Medicine Technology:Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma 2Inogen One Wins Gold Medical Design Excellence Award 2
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... from a family involved in several human diseases is ... new research has found, suggesting that the protein might ... ClC-3 channel, a passageway that allows negatively-charged chloride ions ... circulating insulin of normal mice, according to research published ...
... ... caregivers to voice their concerns about their own health as well as the people who ... ... 2009 -- The ALS Association is encouraging caregivers to voice their concerns about their own ...
... Confirming the full impact of the global recession, philanthropic giving ... 2.9 percent -- or about $241 million -- to $8.6 ... a dramatic 12.9 percent, to total $1.07 billion, according to ... for Healthcare Philanthropy (AHP). , "The poor overall results for ...
... at Arizona State University will use the laws of physics ... treating cancer as a disease and seeking a cure, ASU ... them the way a physicist would, using simple variables like ... a new research center at Arizona State University one ...
... Semen isn,t the only way men spread virus during sex, ... New research suggests that sperm, not just semen, can transmit ... body and, in fact, sperm may play a major role ... HIV, the virus that causes AIDS, can spread the disease ...
... NEW YORK, Oct. 26 Adam Kluger Public Relations ( ... MD ( www.drdennismd.com ) has retained the New ... to promote his psychiatric practice which specializes in sexology, sexual ... sexuality in all its diverse expression should be celebrated. The ...
Cached Medicine News:Health News:Protein critical for insulin secretion may be contributor to diabetes 2Health News:Protein critical for insulin secretion may be contributor to diabetes 3Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 2Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 3Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 4Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 5Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 6Health News:Charitable Giving for U.S. Health Care Rises a Tepid $241 Million in 2008, While Canadian Charitable Giving Plunges 13 Percent, Association for Healthcare Philanthropy Reports 2Health News:Charitable Giving for U.S. Health Care Rises a Tepid $241 Million in 2008, While Canadian Charitable Giving Plunges 13 Percent, Association for Healthcare Philanthropy Reports 3Health News:Charitable Giving for U.S. Health Care Rises a Tepid $241 Million in 2008, While Canadian Charitable Giving Plunges 13 Percent, Association for Healthcare Philanthropy Reports 4Health News:Physical scientists at Arizona State University will apply laws of physics in cancer fight 2Health News:Physical scientists at Arizona State University will apply laws of physics in cancer fight 3Health News:Physical scientists at Arizona State University will apply laws of physics in cancer fight 4Health News:Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr. Dennis Lin, MD to Their All-Star Health and Medical Client Roster 2
... Kubtec introduces a breakthrough in specimen radiography. ... provide up to 65,536 shades of gray in ... capture the smallest changes in density that heretofore ... including digital detectors from 2 x 2 to ...
The Triage Profiler Shortness of Breath Panel provides rapid risk assessment and differential diagnosis of patients presenting to the emergency department with shortness of breath and risk assessment...
... is an affordable path to Sonesta ... seat, and back adjustments. Packaged with ... full line of Sonesta add-ons, allowing ... for your needs; complete Sonesta flexibility ...
... The Sonesta 6202 is ... Packaged with our most popular ... equipped for a myriad of ... powerful (yet quiet) motors allow ...
Medicine Products: